Survival in Type 1 and Type 2 Diabetes in a Population Referred for Invasive Evaluation of Coronary Disease

Per Mølstad1, Olaf Rødevand

  • 1Department of Cardiology, Feiring LHL Clinics, Feiring, Norway.

Cardiology
|December 11, 2017
PubMed

Insights

Patients with type 1 and type 2 diabetes face higher long-term mortality. While mortality has decreased for type 2 diabetes patients, those with type 1 diabetes have not seen similar survival improvements.

Area of Science:

  • Cardiology
  • Endocrinology
  • Public Health

Background:

  • Diabetes mellitus, encompassing type 1 and type 2, is a significant comorbidity in patients undergoing treatment for coronary artery disease.
  • Understanding long-term survival trends in diabetic populations with coronary disease is crucial for effective healthcare management and resource allocation.

Purpose of the Study:

  • To compare long-term survival rates between patients with type 1 diabetes, type 2 diabetes, and those without diabetes undergoing invasive coronary treatment.
  • To analyze temporal trends in mortality for these patient groups over time.

Main Methods:

  • A cohort study of 43,872 patients referred for invasive coronary treatment between March 1999 and December 2014.
  • Survival status was tracked until September 20, 2015, with subgroup analysis for patients with type 1 diabetes (n=1,326) and type 2 diabetes (n=4,564).
  • Cox regression analysis was employed to assess hazard ratios (HR) for mortality, comparing different diabetic statuses and treatment periods (pre- and post-2007).

Main Results:

  • Both type 1 and type 2 diabetes were associated with significantly increased long-term mortality (HR 1.78 and 1.29, respectively).
  • A significant reduction in mortality was observed in patients without diabetes (HR 0.78) and with type 2 diabetes (HR 0.76) in the period after 2007.
  • No significant reduction in mortality was found for patients with type 1 diabetes in the recent treatment period (HR 1.03).

Conclusions:

  • Type 1 and type 2 diabetes are linked to excess long-term mortality in patients with coronary artery disease.
  • Recent improvements in survival observed in non-diabetic and type 2 diabetic patients were not mirrored in the type 1 diabetic cohort.
  • These findings highlight a persistent survival gap for type 1 diabetes patients requiring invasive coronary treatment.
Abstract

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.1K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.5K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.4K
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
14.4K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.2K
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
307